Lonza Group
About
Lonza is a renowned global leader in Bioscience solutions, dedicated to advancing healthcare and promoting healthier lifestyles. Through a combination of cutting-edge technological innovation and unparalleled manufacturing expertise, we empower our customers in the pharmaceutical, biotech, and specialty ingredients industries to bring their groundbreaking discoveries to fruition.
Our commitment to excellence is evident in our wide range of endotoxin and pyrogen testing products, essential for ensuring the safety of parenteral pharmaceutical products and medical devices. Our Monocyte Activation Test (MAT) stands out as a comprehensive solution, capable of detecting both endotoxins and non-endotoxin pyrogens in a single in vitro test.
By incubating samples in human monocytes and measuring cytokines/interleukins (IL) production through immunological assays (ELISA), the MAT provides a reliable method for identifying potential contaminants. In addition to our pioneering testing products, Lonza offers a comprehensive Drug Discovery Portfolio designed to facilitate the development of precise biological model systems.
With a diverse selection of primary cells and optimized cell culture systems, our portfolio serves as a cornerstone for building consistent cellular models with reliable assay performance. By leveraging our integrated solutions, researchers can achieve reproducible results in biologically relevant models, unlocking new possibilities in drug discovery.
As a trusted partner to companies worldwide, Lonza collaborates with industry leaders to deliver high-quality products that complement our existing portfolio. Our strong network of partners ensures that customers have access to a diverse range of resources and expertise, enhancing their research capabilities and driving innovation in the field.
Furthermore, Lonza's Knowledge Centre serves as a valuable resource for researchers, offering insights and application resources to increase efficiency, agility, productivity, and sustainability in scientific endeavors. Whether planning or executing experiments, our library of resources provides invaluable support to researchers seeking solutions for their research needs.
At Lonza, we are dedicated to creating a healthier world through our innovative solutions and unwavering commitment to scientific advancement. By prioritizing patient safety, quality, and collaboration, we continue to shape the future of Bioscience to improve lives and ensure a safer, more sustainable environment. Join us in our mission to enable groundbreaking discoveries and transform the landscape of healthcare for generations to come.
Growth
Lonza is an established enterprise in the bioscience industry, focusing on providing technological innovation and manufacturing excellence to enable the prevention of illness and support healthier lifestyles. The company serves global pharmaceutical, biotech, and specialty ingredients markets, positioning itself as a preferred partner for these industries.
Achievements
Lonza has achieved significant milestones in its history, including the development of innovative products such as the TheraPEAK T-VIVO Cell Culture Medium, TheraPRO CHO Media System, and Nebula Multimode Reader. These products have enhanced drug discovery processes and pyrogen testing, showcasing the company's commitment to improving healthcare and life quality.
Case Studies
Lonza has been involved in numerous case studies demonstrating the effectiveness of its drug discovery portfolio and pyrogen testing products. These studies have highlighted the impact of Lonza's solutions on improving assay performance, developing biological model systems, and ensuring pharmaceutical product safety. The company's commitment to innovation and excellence is evident in these case studies.
Key Events
Lonza has recently launched innovative products like the TheraPEAK T-VIVO Cell Culture Medium and TheraPRO CHO Media System. The company has also expanded its partnerships and collaborations to enhance its product portfolio and offer integrated solutions for drug discovery. Additionally, Lonza has received industry recognition for its technological innovation and commitment to improving healthcare outcomes.
Socials
Founded
1897
Operating Status
Active
Industry
Biotechnology
headquarters
38 Münchensteinerstrasse, Basel Switzerland
Address
Country
Switzerland
Employees
10000
Key People
Products
PyroTec® PRO System
WinKQCL® Software
Endotoxin Testing Reagents
Consumables
Devices
Revenue
['US$ 1B and above']
Operating Income
Stock Price
Why Setting Up a Virtual Delivery Center (VDC) Is Critical for Your Company’s Success
Achieving business success in today’s competitive landscape requires specialized expertise, seamless operations, and continuous innovation. Establishing a Virtual Delivery Center (VDC) can transform your company’s growth journey by ensuring efficiency, scalability, and long-term value.
Why Choose a VDC for Your Company?
1. Cost Optimization:
Save up to 70% on operational costs by leveraging remote teams and streamlined processes.
2. Expert Access:
Gain instant access to highly skilled professionals, ensuring faster and smoother project execution.
3. Scalable Teams:
Scale your team as business needs evolve, from initial project setup to long-term support.
4. Accelerated Timelines:
Leverage 24/7 global teams to reduce project delays and speed up implementation.
5. Continuous Support:
Ensure uninterrupted business performance with ongoing maintenance and updates.
Unlock Business Success with a VDC By establishing a VDC, your company can overcome operational challenges, achieve seamless system integration, and maximize ROI. Stay ahead in today’s dynamic market with a future-ready business strategy powered by a Virtual Delivery Center. Learn More About Us
Book A Meeting To Setup Your VDC
Similar Companies
Welcome to AiDOOS Wiki
AiDOOS Information Wiki provides comprehensive information about products, companies, and individuals.
Lonza Group
-
Website
-
Founded
1897
-
Industry
Biotechnology
-
Headquarters
38 Münchensteinerstrasse, Basel Switzerland
-
Country
Switzerland
-
Number of employees
10000+
-
Revenue
['US$ 1B and above']
About Lonza Group
Lonza is a renowned global leader in Bioscience solutions, dedicated to advancing healthcare and promoting healthier lifestyles. Through a combination of cutting-edge technological innovation and unparalleled manufacturing expertise, we empower our customers in the pharmaceutical, biotech, and specialty ingredients industries to bring their groundbreaking discoveries to fruition.
Our commitment to excellence is evident in our wide range of endotoxin and pyrogen testing products, essential for ensuring the safety of parenteral pharmaceutical products and medical devices. Our Monocyte Activation Test (MAT) stands out as a comprehensive solution, capable of detecting both endotoxins and non-endotoxin pyrogens in a single in vitro test.
By incubating samples in human monocytes and measuring cytokines/interleukins (IL) production through immunological assays (ELISA), the MAT provides a reliable method for identifying potential contaminants. In addition to our pioneering testing products, Lonza offers a comprehensive Drug Discovery Portfolio designed to facilitate the development of precise biological model systems.
With a diverse selection of primary cells and optimized cell culture systems, our portfolio serves as a cornerstone for building consistent cellular models with reliable assay performance. By leveraging our integrated solutions, researchers can achieve reproducible results in biologically relevant models, unlocking new possibilities in drug discovery.
As a trusted partner to companies worldwide, Lonza collaborates with industry leaders to deliver high-quality products that complement our existing portfolio. Our strong network of partners ensures that customers have access to a diverse range of resources and expertise, enhancing their research capabilities and driving innovation in the field.
Furthermore, Lonza's Knowledge Centre serves as a valuable resource for researchers, offering insights and application resources to increase efficiency, agility, productivity, and sustainability in scientific endeavors. Whether planning or executing experiments, our library of resources provides invaluable support to researchers seeking solutions for their research needs.
At Lonza, we are dedicated to creating a healthier world through our innovative solutions and unwavering commitment to scientific advancement. By prioritizing patient safety, quality, and collaboration, we continue to shape the future of Bioscience to improve lives and ensure a safer, more sustainable environment. Join us in our mission to enable groundbreaking discoveries and transform the landscape of healthcare for generations to come.
Why Setting Up a Virtual Delivery Center (VDC) Is Critical for Your Company’s Success
Achieving business success in today’s competitive landscape requires specialized expertise, seamless operations, and continuous innovation. Establishing a Virtual Delivery Center (VDC) can transform your company’s growth journey by ensuring efficiency, scalability, and long-term value.
Why Choose a VDC for Your Company?
1. Cost Optimization:
Save up to 70% on operational costs by leveraging remote teams and streamlined processes.
2. Expert Access:
Gain instant access to highly skilled professionals, ensuring faster and smoother project execution.
3. Scalable Teams:
Scale your team as business needs evolve, from initial project setup to long-term support.
4. Accelerated Timelines:
Leverage 24/7 global teams to reduce project delays and speed up implementation.
5. Continuous Support:
Ensure uninterrupted business performance with ongoing maintenance and updates.
Unlock Business Success with a VDC By establishing a VDC, your company can overcome operational challenges, achieve seamless system integration, and maximize ROI. Stay ahead in today’s dynamic market with a future-ready business strategy powered by a Virtual Delivery Center. Learn More About Us
Book A Meeting To Setup Your VDC
